Jim Cramer is opting for stocks like Allergan and Johnson & Johnson over Valeant Pharmaceuticals.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer is keeping an eye on quarterly results from Valeant Pharmaceuticals on Tuesday.
Without further ado, here's a look at this week's Rocket Stocks.
These stocks are showing short-term gain catalysts and longer-term growth potential. Here's how to trade them.